Boston Scientific Q2 2026 Sales Growth Beat Expectations
Boston Scientific reported solid Q2 2026 sales growth, growth in all segments, and completed a $2 billion share repurchase. The adjusted EPS was ahead of guidance.
View filing at SEC.gov →1 most recent filing and news item mentioning BSX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/BSX/news?limit=20"
Pull BSX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayBoston Scientific reported solid Q2 2026 sales growth, growth in all segments, and completed a $2 billion share repurchase. The adjusted EPS was ahead of guidance.
View filing at SEC.gov →